Treatments in Endocrinology

, Volume 1, Issue 6, pp 387–398

Management of Obesity in the Elderly

Special Considerations
Review Article


Over the last few decades, there has been an unprecedented increase in the prevalence of obesity, especially in economically developed countries. Furthermore, it is becoming an increasingly recognized health problem in the elderly.

The precise mechanisms underlying increased adiposity in the elderly are not known. Aging is associated with a host of biologic changes that limit the ability of the individual to regulate energy homeostasis. Thus, it is likely that older individuals may be more likely to develop the two extremes of the spectrum of nutritional abnormalities, namely malnutrition and increased adiposity. These nutritional abnormalities are associated with significant morbidity and mortality. Current guidelines define overweight as a body mass index (BMI) of 25–29.9 kg/m2 and obesity as a BMI of 30 kg/m2 or more. However, the optimal BMI may be different in older individuals.

Management strategies should attempt to optimize the nutritional status of older individuals. Age per se cannot be used as a justification for denying medical management of obesity to elderly individuals. Individualized programs with the goal of achieving modest weight reduction in obese patients are likely to result in immediate (e.g. alleviation of arthritic pains and reduction of glucose intolerance) and possibly long-term (e.g. reduction in cardiovascular risk) healthcare benefits. Management should emphasize lifestyle modifications, while the use of pharmacologic agents such as sibutramine and orlistat should be reserved for select groups of patients who do not respond to lifestyle modification.


  1. 1.
    Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195–200PubMedCrossRefGoogle Scholar
  2. 2.
    Kinsella K. Demographic aspects. In: Ebrahim S, Kalache A, editors. Epidemiology in old age. London: BMJ Publishing 1996: 32–40Google Scholar
  3. 3.
    Spiegelman D, Israel RG, Bouchard C, et al. Absolute fat mass, percent body fat, and body-fat distribution: which is the real determinant of blood pressure and serum glucose? Am J Clin Nutr 1992; 55: 1033–44PubMedGoogle Scholar
  4. 4.
    Willett WC. Nutritional epidemiology. 2nd ed. New York: Oxford University Press, 1998CrossRefGoogle Scholar
  5. 5.
    Pincivero DM, Bompa TO. A physiological review of American football. Sports Med 1997; 23: 247–60PubMedCrossRefGoogle Scholar
  6. 6.
    Dequeker JV, Baeyens JP, Glaessens J. The significance of stature as a clinical measurement of ageing. J Am Gerontolol Soc 1969; 17: 169–79Google Scholar
  7. 7.
    Mitchell CO, Lipschitz DA. Detection of protein-calorie malnutrition in the elderly. Am J Clin Nutr 1982; 35: 398–406PubMedGoogle Scholar
  8. 8.
    Wahlqvist MI, Flint DM. Assessment of loss of height in elderly women. Eur J Clin Nutr 1988; 42: 679–82PubMedGoogle Scholar
  9. 9.
    Prothro JW, Rosenbloom CA. Physical measurements in an elderly black population: knee height as the dominant indicator of stature. J Gerontol 1993; 48: M15–8PubMedCrossRefGoogle Scholar
  10. 10.
    MuncieJr HL, Sobal J, Hoopes JM, et al. A practical method of estimating stature of bedridden female nursing home patients. J Am Geriatr Soc 1987; 35: 285–9PubMedGoogle Scholar
  11. 11.
    National Institutes of Health, National Heart, Lung, and Blood Institute. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998; 158: 1855–67CrossRefGoogle Scholar
  12. 12.
    Baumgartner RN, Heymsfield SB, Roche AF. Human body composition and the epidemiology of chronic disease. Obes Res 1995; 3: 73–95PubMedGoogle Scholar
  13. 13.
    Flegal KM, Carrol MD, Kucznavski RJ, et al. Overweight and obesity in the states: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998; 22: 39–47PubMedCrossRefGoogle Scholar
  14. 14.
    Wallace JI, Schwartz RS. Involuntary weight loss in elderly outpatient: recognition, etiologies, and treatment. Clin Geriatr Med 1997; 13(4): 717–35PubMedGoogle Scholar
  15. 15.
    Morley JE. Anorexia in older person: epidemiology and optimal treatment. Drugs Aging 1996; 8(2): 134–55PubMedCrossRefGoogle Scholar
  16. 16.
    Clarkston WK, Pantano MM, Morley JE, et al. Evidence for the anorexia of aging: gastrointestinal transit and hunger in healthy elderly young adults. Am J Physiol 1997; 272: R243–8PubMedGoogle Scholar
  17. 17.
    Morley JE. Anorexia of aging: physiologic and pathologic. Am J Clin Nutr 1997; 66: 760–73PubMedGoogle Scholar
  18. 18.
    Morley JE. Anorexia, body composition, and ageing. Curr Opin Clin Nutr Metab Care 2001; 4: 9–13PubMedCrossRefGoogle Scholar
  19. 19.
    Lin CC, Li TC, Lai SW, et al. Epidemiology of obesity in elderly people. Yale J Biol Med 1999; 72: 385–91PubMedGoogle Scholar
  20. 20.
    Mooradian AD. Biology of aging. In: Felsenthal G, Garrison SJ, Steinberg FU, editors. Rehabilitation of the aging and elderly patient. Baltimore (MD): Williams and Wilkins, 1994: 3–10Google Scholar
  21. 21.
    Goran MI, Poehlman ET. Total energy expenditure and energy requirements in healthy elderly persons. Metabolism 1992; 41: 744–53PubMedCrossRefGoogle Scholar
  22. 22.
    Mooradian AD. Mechanisms of age-related endocrine alterations in mammals: part I. Drugs Aging 1993; 3: 81–97PubMedCrossRefGoogle Scholar
  23. 23.
    Mooradian AD. Mechanisms of age-related endocrine alterations in mammals: part II. Drugs Aging 1993; 3: 131–46PubMedCrossRefGoogle Scholar
  24. 24.
    Scarpace PJ, Mooradian AD, Morley JE. Age-associated decrease in beta adrenergic receptors and adenylate cyclase activity in rat brown adipose tissue. J Gerontol 1988; 43: B65–70PubMedCrossRefGoogle Scholar
  25. 25.
    Mooradian AD, Habib MP, Dickerson F, et al. The effect of age on L-3,5,3′,triiodothyronine induced ethane exhalation. J Appl Physiol 1994; 77: 160–4PubMedGoogle Scholar
  26. 26.
    Mooradian AD, Habib MP, Dickerson F. Age-related changes in the effect of simple carbohydrates, casein hydrolysate and a lipid test meal on ethane exhalation rate. J Appl Physiol 1994; 76: 1119–22PubMedGoogle Scholar
  27. 27.
    Mooradian AD, Wong NCW. Age-related changes in thyroid hormone action. Eur J Endocrinol 1994; 131: 451–61PubMedCrossRefGoogle Scholar
  28. 28.
    Mooradian AD. Normal age-related changes in thyroid hormone economy. Clin Geriatr Med 1995; 11: 159–69PubMedGoogle Scholar
  29. 29.
    Silverberg AB, Mooradian AD. The thyroid and aging. In: Mobbs ChV, Hof PR, editors. Interdisciplinary topics In aging, functional endocrinology of ageing. New York: Kaigel, 1998; 29: 27–43CrossRefGoogle Scholar
  30. 30.
    Mooradian AD. Blood-brain transport of triiodothyronine is reduced in aged rats. Mech Age Dev 1990; 52: 141–7CrossRefGoogle Scholar
  31. 31.
    Mooradian AD. The hepatic transcellular transport of 3,5,3′-triiodothyronine is reduced in aged rats. Biochim Biophys Acta 1990; 1054: 1–7PubMedCrossRefGoogle Scholar
  32. 32.
    Florini JR, Prinz, PN, et al. Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. J Gerontol 1985; 40: 2–7PubMedCrossRefGoogle Scholar
  33. 33.
    Pavlov EP, Harman SM, Merriam GR, et al. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1986; 62: 595–600PubMedCrossRefGoogle Scholar
  34. 34.
    Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993; 14: 20–39PubMedGoogle Scholar
  35. 35.
    Iovino M, Monteleone P, Steardo L. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging. J Clin Endocrinol Metab 1989; 69: 910–3PubMedCrossRefGoogle Scholar
  36. 36.
    Russell-Aulet M, Jaffe CA, Demott-Friberg R, et al. In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging. J Clin Endocrinol Metab 1999; 84: 3490–7PubMedCrossRefGoogle Scholar
  37. 37.
    Vahl N, Jorgensen JO, Jurik AG, et al. Abdominal adiposity and physical fitness are major determinants of the age-associated decline in stimulated GH secretion in health adults. J CLin Endocrinol Metab 1996; 81: 2209–15PubMedCrossRefGoogle Scholar
  38. 38.
    Mooradian AD, Morley JE, Korenman SK. The biological actions of androgens. Endocr Rev 1987; 8: 1–28PubMedCrossRefGoogle Scholar
  39. 39.
    Korenman SG, Mooradian AD, Hendrick V. Changes in men as they age: the manopause. In: Lobo RA, Kelsey J, Marcus R, editors. Menopause: biology and pathobiology. San Diego (CA): Academic Press, 2000: 111–33Google Scholar
  40. 40.
    Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002; 57: M76–99PubMedCrossRefGoogle Scholar
  41. 41.
    Tenover JL. Testosterone and aging male. J Androl 1997; 18: 103–6PubMedGoogle Scholar
  42. 42.
    Isidori AM, Strollo F, Morè M, et al. Leptin and aging: Correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000; 85: 1954–62PubMedCrossRefGoogle Scholar
  43. 43.
    Neuhauser-Berthold M, Herbert BM, Luhrmann PM, et al. Resting metabolic rate, body composition, and serum leptin concentrations in a free-living elderly population. Eur J Endocrinol 2000; 142: 486–92PubMedCrossRefGoogle Scholar
  44. 44.
    Dua A, Hennes MI, Hoffmann RG, et al. Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 1996; 45: 1635–7PubMedCrossRefGoogle Scholar
  45. 45.
    Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002; 51: 1005–15PubMedCrossRefGoogle Scholar
  46. 46.
    Baumgartner RN, Ross RR, Waters DL, et al. Serum leptin in elderly people: associations with sex hormones, insulin, and adipose tissue volumes. Obes Res 1999; 7: 141–9PubMedGoogle Scholar
  47. 47.
    Baumgartner RN, Waters DL, Morley JE, et al. Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat. Metabolism 1999; 48: 378–84PubMedCrossRefGoogle Scholar
  48. 48.
    Sih R, Morley JE, Kaiser FE, et al. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82: 1661–7PubMedCrossRefGoogle Scholar
  49. 49.
    Scarpace PJ, Turner N. Peripheral and hypothalamic leptin resistance with age-related obesity. Physiol Behav 2001; 74: 721–7PubMedCrossRefGoogle Scholar
  50. 50.
    Shek EW, Scarpace PJ. Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats. Regul Peptides 2000; 92: 65–71CrossRefGoogle Scholar
  51. 51.
    Mooradian AD, Hurd R, Chehade J, et al. Age-related changes in plasma leptin binding activity in rats. A comparison of a simple acid-ethanol precipitation technique with column chromatography. Proc Soc. Exp Biol Med 2000; 224: 273–7PubMedCrossRefGoogle Scholar
  52. 52.
    Scarpace PJ, Matheny M, Turner N. Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats. Neuroscience 2001; 104: 1111–7PubMedCrossRefGoogle Scholar
  53. 53.
    Reed RL, Perlmutter L, Yochum K, et al. The relationship between muscle mass and muscle strength in the elderly. J Am Geriatr Soc 1991; 39: 551–61Google Scholar
  54. 54.
    Mojet J, Christ-Hazelhof E, Heidema J. Taste perception with age: generic or specific losses in threshold sensitivity to the five basic tastes? Chem Senses 2001; 26: 845–60PubMedCrossRefGoogle Scholar
  55. 55.
    Morley JE. Decreased food intake with aging. J Gerontol Biol Sci Med Sci 2001; 56 Spec. No. 2: 81–8CrossRefGoogle Scholar
  56. 56.
    Allison DB, Gallager D, Pi-Sunyer FX, et al. Body mass index and all-cause mortality among people age 70 and over: the longitudinal study of aging. Int J Obes 1997; 21: 424–31CrossRefGoogle Scholar
  57. 57.
    Cornoni-Huntley JC, Harris TB, Everett DF, et al. An overview of body weight of older persons, including the impact on mortality: the National Health and Nutrition Examination Survey I -Epidemiologic Follow-Up Study. J Clin Epidemiol 1991; 44: 743–53PubMedCrossRefGoogle Scholar
  58. 58.
    Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in older women. JAMA 1993; 269: 483–7PubMedCrossRefGoogle Scholar
  59. 59.
    Ho SC, Woo J, Sham A. Risk factor change in older persons, a perspective from Hong Kong: weight change and mortality. J Gerontol 1994; 49: M269–72PubMedCrossRefGoogle Scholar
  60. 60.
    Rissanen A, Heliovaara M, Knekt P, et al. Weight and mortality in Finnish men. J Clin Epidemiol 1989; 42: 781–9PubMedCrossRefGoogle Scholar
  61. 61.
    Rissanen A, Knekt P, Heliovaara M, et al. Weight and mortality in Finnish women. J Clin Epidemiol 1991; 44: 787–95PubMedCrossRefGoogle Scholar
  62. 62.
    Grabowski DC, Ellis JE. High body mass index does not predict mortality in older people: analysis of the Longitudinal Study of Aging. J Am Geriatr Soc 2001; 49: 968–79PubMedCrossRefGoogle Scholar
  63. 63.
    Campbell AJ, Spears GF, Brown JS, et al. Anthropometric measurements as predictors of mortality in a community population aged 70 years and over. Age Ageing 1990; 19: 131–5PubMedCrossRefGoogle Scholar
  64. 64.
    Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body mass index and mortality. N Engl J Med 1998; 338: 1–7PubMedCrossRefGoogle Scholar
  65. 65.
    Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 2001; 161: 1194–203PubMedCrossRefGoogle Scholar
  66. 66.
    Tayback M, Kamanyika S, Chee E. Body weight as a risk factor in the elderly. Arch Intern Med 1990; 150: 1065–72PubMedCrossRefGoogle Scholar
  67. 67.
    Lindstead K, Singh PN. Body mass and 26-year risk of mortality among women who never smoked: findings from the Adventist Mortality Study. Am J Epidemiol 1997; 146: 1–11CrossRefGoogle Scholar
  68. 68.
    Kamel HK, Iqbal MA. Body mass index and mortality among hospitalized elderly patients. Arch Intern Med 2001; 161: 1459–60PubMedCrossRefGoogle Scholar
  69. 69.
    Allison DB, Zannolli R, Faith MS, et al. Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies. Int J Obes Relat Metab Disord 1999; 23: 603–11PubMedCrossRefGoogle Scholar
  70. 70.
    Ryan AS. Insulin resistance with aging: effects of diet and exercise. Sports Med 2000; 30: 327–46PubMedCrossRefGoogle Scholar
  71. 71.
    Purnell JQ, Kahn SE, Albers JJ, et al. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab 2000; 85: 977–82PubMedCrossRefGoogle Scholar
  72. 72.
    Imbeault P, Vidal H, Tremblay A, et al. Age-related differences in messenger ribonucleic acid expression of key proteins involved in adipose cell differentiation and metabolism. J Clin Endocrinol Metab 2001; 86: 828–33PubMedCrossRefGoogle Scholar
  73. 73.
    Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998; 6: 97–106PubMedGoogle Scholar
  74. 74.
    Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–9PubMedCrossRefGoogle Scholar
  75. 75.
    Morris RD, Rimm DL, Hartz AJ, et al. Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women. Am J Epidemiol 1989; 130: 112–21PubMedGoogle Scholar
  76. 76.
    Bray GA. Obesity increases risk for diabetes. Relat Metab Disord 1992; 16: S13–7Google Scholar
  77. 77.
    Felber JP, Acheson KJ, Tappy L. From obesity to diabetes. New York: Wiley, 1993Google Scholar
  78. 78.
    Mooradian AD, Kalis J, Nugent CA. The nutritional status of ambulatory elderly type II diabetic patients. Age 1990; 13: 87–9CrossRefGoogle Scholar
  79. 79.
    Mooradian AD, Osterweil D, Petrasek D, et al. Diabetes mellitus in elderly nursing home patients: a survey of clinical characteristics and management. J Am Geriatr Soc 1988; 36: 391–6PubMedGoogle Scholar
  80. 80.
    Knowler WC, Pettitt DJ, Savage PJ, et al. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 1981; 113: 144–56PubMedGoogle Scholar
  81. 81.
    Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481–6PubMedGoogle Scholar
  82. 82.
    Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961–9PubMedCrossRefGoogle Scholar
  83. 83.
    Ferrannini E, Barrett EJ, Bevilacqua S, et al. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983; 72: 1737–47PubMedCrossRefGoogle Scholar
  84. 84.
    Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859–65PubMedCrossRefGoogle Scholar
  85. 85.
    Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidyl-inositol 3-kinase activity. J Clin Invest 1999; 103: 253–9PubMedCrossRefGoogle Scholar
  86. 86.
    Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91PubMedCrossRefGoogle Scholar
  87. 87.
    Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 1996; 271: 665–8PubMedCrossRefGoogle Scholar
  88. 88.
    Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185–8PubMedCrossRefGoogle Scholar
  89. 89.
    Taylor SI, Barr V, Reitman M. Does leptin contribute to diabetes caused by obesity? Science 1996; 274: 1151–2PubMedCrossRefGoogle Scholar
  90. 90.
    Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998; 97: 2099–100PubMedCrossRefGoogle Scholar
  91. 91.
    Harris T, Cook EF, Kannel WB, et al. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 and older: the Framingham Heart Study. J Am Geriatr Soc 1988; 36: 1023–8PubMedGoogle Scholar
  92. 92.
    Harris T, Ballard-Barbasch R, Madans J, et al. Overweight, weight loss and risk of coronary heart disease in older women: the NHANES I epidemiologic follow-up study. Am J Epidemiol 1993; 137: 1318–27PubMedGoogle Scholar
  93. 93.
    Harris TB, Launer LJ, Madanas J, et al. Cohort study of effect of being overweight and change in weight on risk of coronary artery disease in old age. BMJ 1997; 314: 1791–4PubMedCrossRefGoogle Scholar
  94. 94.
    Higgins M, D’Agostino R, Kannel W, et al. Benefits and adverse effects of weight loss: observations from the Framingham Study. Ann Intern Med 1993; 119 Suppl. 2: 758–63PubMedGoogle Scholar
  95. 95.
    Pamuk ER, Williamson DF, Sedula MK, et al. Weight loss and subsequent death in a cohort of U.S. adults. Ann Intern Med 1993; 119 Suppl. 2: 744–8PubMedGoogle Scholar
  96. 96.
    Blair SN, Shaton J, Brownell K, et al. Body weight change, all-cause and cause-specific mortality in the multiple risk factor intervention trial. Ann Intern Med 1993; 119 Suppl. 2:749–57PubMedGoogle Scholar
  97. 97.
    Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk. Cancer Causes Control 2001; 12: 13–21PubMedCrossRefGoogle Scholar
  98. 98.
    Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91: 421–30PubMedCrossRefGoogle Scholar
  99. 99.
    Hubert HB, Bloch DA, Fries JF. Risk factors for physical disability in an aging cohort: the NHANES I Epidemiologic Follow-up Study. J Rheumatol 1993; 20: 480–8PubMedGoogle Scholar
  100. 100.
    Launer LJ, Harris T, Rumpel C, et al. Body mass index, weight change, and risk of mobility disability in middle-aged and older women. JAMA 1994; 271: 1093–8PubMedCrossRefGoogle Scholar
  101. 101.
    Apovian C, Frey C, Rogers J, et al. Body mass index and physical function in obese older women. J Am Geriatr Soc 1996; 44: 1487–8PubMedGoogle Scholar
  102. 102.
    Nguyen TV, Center JR, Eisman JA. Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index. J Bone Miner Res 2000; 15: 322–231PubMedCrossRefGoogle Scholar
  103. 103.
    van der Voort DJ, Brandon S, Dinant GJ, et al. Screening for osteoporosis using easily obtainable biometrical data: Diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements. Osteoporos Int 2000; 11: 233–9PubMedCrossRefGoogle Scholar
  104. 104.
    Pfeifer M, Begerow B, Minne HW, et al. Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 2001; 109: 87–92PubMedCrossRefGoogle Scholar
  105. 105.
    Williamson DF, Pamuk E, Thun M, et al. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol 1995; 141: 1128–41PubMedGoogle Scholar
  106. 106.
    Uusitupa M, Louheranta A, Lindstrom J, et al. The Finnish Diabetes Prevention Study. Br J Nutr 2000; 83 Suppl. 1: S137–42PubMedCrossRefGoogle Scholar
  107. 107.
    Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403PubMedCrossRefGoogle Scholar
  108. 108.
    Wing RR, Blair E, Bononi P, et al. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994; 17: 30–6PubMedCrossRefGoogle Scholar
  109. 109.
    Wing RR, Koeske R, Epstein LH, et al. Long term effects of modest weight loss in type II diabetic patients. Arch. Intern Med 1987; 147: 1749–53PubMedCrossRefGoogle Scholar
  110. 110.
    Heath GW, Wilson RH, Smith J, et al. Community-based exercise and weight control: diabetes risk reduction and glycemic control in Zuni Indians. Am J Clin Nutr 1991; 53 Suppl. 6: 1642S–6SPubMedGoogle Scholar
  111. 111.
    Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of non pharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998; 279: 839–46PubMedCrossRefGoogle Scholar
  112. 112.
    Mooradian AD. Nutritional modulation of life span and gene expression. In: Morley JE, moderator. Nutrition in the elderly. Ann Intern Med 1988; 109: 890-904Google Scholar
  113. 113.
    Hegsted DM. Recommended dietary intakes of elderly subjects. Am J Clin Nutr 1989; 50: 1190–4; discussion 1231-5PubMedGoogle Scholar
  114. 114.
    Roza AM, Shizgal HM. The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass. Am J Clin Nutr 1984; 40: 168–82PubMedGoogle Scholar
  115. 115.
    Campbell WW, Trappe TA, Wolfe RR, et al. The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol A Biol Sci Med Sci 2001; 56: M373–80PubMedCrossRefGoogle Scholar
  116. 116.
    Paauw JD, McCamish MA, Dean RE, et al. Assessment of caloric needs in stressed patients. J Am College Nutr 1984; 3: 51–9Google Scholar
  117. 117.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2000; 285: 2486–97CrossRefGoogle Scholar
  118. 118.
    American Diabetes Association. American Diabetes Association Position Statement: evidence-based nutrition principles and recommendations for treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25 Suppl. 1: S50–60CrossRefGoogle Scholar
  119. 119.
    Castaneda C, Gordon PL, Fielding RA, et al. Marginal protein intake results in reduced plasma IGF-I levels and skeletal muscle fiber atrophy in elderly women. J Nutr Health Aging 2000; 4: 85–90PubMedGoogle Scholar
  120. 120.
    Pescatello LS, Dipeietro I. Physical activity in older adults: an overview of health benefits. Sports Med 1993; 6: 353–64CrossRefGoogle Scholar
  121. 121.
    Krotkiewski M, Lonnroth P, Mandroukas K, et al. The effect of physical training on insulin secretion and effectiveness, and on glucose metabolism in obesity and type 2 (non insulin dependent) diabetes mellitus. Diabetologia 1985; 28:881–90PubMedCrossRefGoogle Scholar
  122. 122.
    Reed R, Yochum K, Perlmutter L, et al. The interrelationship between physical exercise, muscle strength and body adiposity in healthy elderly population. J Am Geriatr Soc. 1991; 39: 1189–93PubMedGoogle Scholar
  123. 123.
    Fiaterone MA, O’Neill EF, Ryan ND, et al.Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330: 1769–75CrossRefGoogle Scholar
  124. 124.
    Dvorak R, Starling RD, Calles-Escandon J, et al. Drug therapy for obesity in the elderly. Drugs Aging 1997; 11: 338–51PubMedCrossRefGoogle Scholar
  125. 125.
    Wellman PJ. Overview of adrenergic anorectic agents. Am J Clin Nutr 1992; 55 Suppl. 1: 193S–8SPubMedGoogle Scholar
  126. 126.
    Bray GA, Ryan DH, Gordon D, et al. A double-blind, randomized, placebo-controlled trial of sibutramine. Obes Res 1996; 4: 263–70PubMedGoogle Scholar
  127. 127.
    McMahon FG, Jujioka K, Singh BN, et al. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med 2000; 160: 2185–91PubMedCrossRefGoogle Scholar
  128. 128.
    Apfelbaum M, Vague P, Ziegler O, et al. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999; 106: 179–84PubMedCrossRefGoogle Scholar
  129. 129.
    James PT, Astrup A, Finer N, et al. The STORM Study Group Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 2000; 356: 2119–25PubMedCrossRefGoogle Scholar
  130. 130.
    Hazenberg BP. Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients. Cardiology 2000; 94(3): 152–8PubMedCrossRefGoogle Scholar
  131. 131.
    Sjostrom L, Rissanen A, Andersen T, et al. Randomized, placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352: 167–73PubMedCrossRefGoogle Scholar
  132. 132.
    Mittendorfer B, OstlundJr RE, Patterson BW, et al. Orlistat inhibits dietary cholesterol absorption. Obes Res 2001; 9: 599–604PubMedCrossRefGoogle Scholar
  133. 133.
    Hauptman J, Lucas C, Boldrin MN, et al. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 2000; 9: 160–7PubMedCrossRefGoogle Scholar
  134. 134.
    Davison MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 1999; 281: 235–42CrossRefGoogle Scholar
  135. 135.
    Tonstad S, Pometta D, Erkelens DW, et al. The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol 1994; 46: 405–10PubMedCrossRefGoogle Scholar
  136. 136.
    Miles JM, Leiter L, Hollander P, et al. Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes Care 2002; 25: 1123–8PubMedCrossRefGoogle Scholar
  137. 137.
    Thurman J, Mooradian AD. Vitamin supplementation therapy in the elderly. Drugs Aging 1997; 11: 433–49PubMedCrossRefGoogle Scholar
  138. 138.
    Mooradian AD. Obesity: a rational target for managing diabetes mellitus. Growth Horm IGF Res 2001; 11 Suppl. A: S1–5Google Scholar
  139. 139.
    Murray RD, Shalet SM. Growth hormone: current and future therapeutic applications. Expert Opin Pharmacother 2001; 1: 975–90CrossRefGoogle Scholar
  140. 140.
    Cummings DE, Merriam GR. Age-related changes in growth hormone secretion: should the somatopause be treated? Semin Reprod Endocrinol 1999; 17: 311–25PubMedGoogle Scholar
  141. 141.
    Maccario M, Tassone F, Gauna C, et al. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing’s syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol 2001; 144: 251–6PubMedCrossRefGoogle Scholar
  142. 142.
    Svensson J, Bengtsson BA, Taskinen MR, et al. A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men. Growth Horm IGF Res 2000; 10: 118–6PubMedCrossRefGoogle Scholar
  143. 143.
    Marin P, Holmang S, Gustafsson C, et al. Androgen treatment of abdominally obese men. Obes Res 1993; 1: 245–51PubMedGoogle Scholar
  144. 144.
    Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1–6PubMedCrossRefGoogle Scholar
  145. 145.
    Yarasheski KE, Zachwieja JJ, Campbell JA, et al. Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol 1995; 268: E268–76PubMedGoogle Scholar
  146. 146.
    Taaffe DR, Jin IH, Vu TH, et al. Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men. J Clin Endocrinol Metab 1996; 81: 421–5PubMedCrossRefGoogle Scholar
  147. 147.
    Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of growth hormone-releasing hormone in age-advanced men and women. J Clin Endocrinol Metab 1997; 82: 1472–9PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Authors and Affiliations

  1. 1.Division of Endocrinology, Department of Internal Medicine, Diabetes and MetabolismSt Louis University School of MedicineSt LouisUSA

Personalised recommendations